/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | NVAXNOVAVAX INC |
|---|---|
| Last close | $8.42 |
| Change % | -4.21% |
| Market cap | $1.4B |
| P/E | 3.3 |
| Revenue | $1.1B |
| Rev growth (YoY) | 64.7% |
| Net income | $440M |
| Net margin | 39.2% |
| EPS (diluted) | $2.58 |
| Piotroski F-ScoreUNVALIDATED | 5 |
| Altman Z-ScoreUNVALIDATED | -2.04 |
| Beneish M-ScoreUNVALIDATED | — |
| Next earnings | 10-31 → 11-10 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.